Sangamo Therapeutics Quote - GBY

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

1.1894

Bid

1.156

Ask

1.1848

Volume

0.00

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

248.165M

Previous Close

1.1894

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

208,646,870

Dividend Yield

PE Ratio

-1.00

Earnings Per Share (EPS)

-1.24

Revenue

176.23M

Net Profit

-257.83M

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.sangamo.com

Headquarters

Wilmington, Delaware, USA

Founded

Sangamo Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the Tradegate (DE) with ticker GBY. The last closing price for Sangamo Therapeutics was 1.19 €. Over the last year, Sangamo Therapeutics shares have traded in a share price range of 0.00 € to 0.00 €.

Sangamo Therapeutics currently has 208,646,870 shares outstanding. The market capitalization of Sangamo Therapeutics is 248.16 € million. Sangamo Therapeutics has a price to earnings ratio (PE ratio) of -1.00.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

GBY - Frequently Asked Questions (FAQ)

What is the current Sangamo Therapeutics share price?

The current share price of Sangamo Therapeutics is 1.1894 €

How many Sangamo Therapeutics shares are in issue?

Sangamo Therapeutics has 208,646,870 shares in issue

What is the market cap of Sangamo Therapeutics?

The market capitalisation of Sangamo Therapeutics is EUR 248.16M

What is the 1 year trading range for Sangamo Therapeutics share price?

Sangamo Therapeutics has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Sangamo Therapeutics?

The price to earnings ratio of Sangamo Therapeutics is -1

What is the cash to sales ratio of Sangamo Therapeutics?

The cash to sales ratio of Sangamo Therapeutics is 1.47

What is the reporting currency for Sangamo Therapeutics?

Sangamo Therapeutics reports financial results in USD

What is the latest annual turnover for Sangamo Therapeutics?

The latest annual turnover of Sangamo Therapeutics is USD 176.23M

What is the latest annual profit for Sangamo Therapeutics?

The latest annual profit of Sangamo Therapeutics is USD -257.83M

What is the registered address of Sangamo Therapeutics?

The registered address for Sangamo Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Sangamo Therapeutics website address?

The website address for Sangamo Therapeutics is www.sangamo.com

Which industry sector does Sangamo Therapeutics operate in?

Sangamo Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
L7C2Windfall Geotek Inc	0.0145 € (70.59%)	9.16k
E3O1Nexoptic Technology Corp	0.023 € (48.39%)	627
VOPInvestigator Resources Ltd	0.02 € (42.86%)	1.85k
2TUTaruga Minerals Limited	0.0075 € (25.00%)	134
TYSTokyo Seimitsu	55.30 € (21.54%)	81
EUSKore Mining Ltd	0.013 € (-42.22%)	6k
NHYLucapa Diamond Company Ltd	0.0105 € (-27.59%)	9.6k
UH7ATennant Minerals NL	0.0055 € (-26.67%)	3.38k
YBBCarnavale Resources Ltd	0.0015 € (-25.00%)	2.4k
4B4Australian Silica Quartz Group Limited	0.0135 € (-20.59%)	54.7k
D7GNel ASA	0.1934 € (-0.67%)	488.84k
VODIVodafone Group plc	0.7972 € (1.06%)	394.81k
CBKCommerzbank AG	18.46 € (0.27%)	354.08k
BSD2Banco Santander SA	5.369 € (8.59%)	300.17k
Q3JGlobal Uranium Corp	0.358 € (-9.14%)	257.04k